NFκB activation by Fas is mediated through FADD, caspase-8, and RIP and is inhibited by FLIP

被引:202
作者
Kreuz, S
Siegmund, D
Rumpf, JJ
Samel, D
Leverkus, M
Janssen, O
Häcker, G
Dittrich-Breiholz, O
Kracht, M
Scheurich, P
Wajant, H
机构
[1] Univ Wurzburg, Med Polyclin, Dept Mol Internal Med, D-97070 Wurzburg, Germany
[2] Univ Stuttgart, Inst Cell Biol & Immunol, D-70569 Stuttgart, Germany
[3] Univ Wurzburg, Sch Med, Dept Dermatol, D-97080 Wurzburg, Germany
[4] Med Ctr Schlewsig Holstein, Inst Immunol, D-24105 Kiel, Germany
[5] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany
[6] Hannover Med Sch, Inst Pharmacol, D-30625 Hannover, Germany
关键词
apoptosis; Bcl2; CD95; FasL; IL8;
D O I
10.1083/jcb.200401036
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
F as (APO-1/CD95) is the prototypic death receptor, and the molecular mechanisms of Fas-induced apoptosis are comparably well understood. Here, we show that Fas activates NFkappaB via a pathway involving RIP, FADD, and caspase-8. Remarkably, the enzymatic activity of the latter was dispensable for Fas-induced NFkappaB signaling pointing to a scaffolding-related function of caspase-8 in nonapoptotic Fas signaling. NFkappaB was activated by overexpressed FLIPL and FLIPs in a cell type-specific manner. However, in the context of Fas signaling both isoforms blocked FasL-induced NFkappaB activation. Moreover, down-regulation of both endogenous FLIP isoforms or of endogenous FLIPL alone was sufficient to enhance FasL-induced expression of the NFkappaB target gene IL8. As NFkappaB signaling is inhibited during apoptosis, FasL-induced NFkappaB activation was most prominent in cells that were protected by Bcl2 expression or caspase inhibitors and expressed no or minute amounts of FLIP. Thus, protection against Fas-induced apoptosis in a FLIP-independent manner converted a proapoptotic Fas signal into an inflammatory NFkappaB-related response.
引用
收藏
页码:369 / 380
页数:12
相关论文
共 58 条
[1]   The CD95 type I/type II model [J].
Barnhart, BC ;
Alappat, EC ;
Peter, ME .
SEMINARS IN IMMUNOLOGY, 2003, 15 (03) :185-193
[2]   A unified model for apical caspase activation [J].
Boatright, KM ;
Renatus, M ;
Scott, FL ;
Sperandio, S ;
Shin, H ;
Pedersen, IM ;
Ricci, JE ;
Edris, WA ;
Sutherlin, DP ;
Green, DR ;
Salvesen, GS .
MOLECULAR CELL, 2003, 11 (02) :529-541
[3]   Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development [J].
Cecconi, F ;
Alvarez-Bolado, G ;
Meyer, BI ;
Roth, KA ;
Gruss, P .
CELL, 1998, 94 (06) :727-737
[4]   Activation of the NF-κB pathway by Caspase 8 and its homologs [J].
Chaudhary, PM ;
Eby, MT ;
Jasmin, A ;
Kumar, A ;
Liu, L ;
Hood, L .
ONCOGENE, 2000, 19 (39) :4451-4460
[5]   Fas engagement induces neurite growth through ERK activation and p35 upregulation [J].
Desbarats, J ;
Birge, RB ;
Mimouni-Rongy, M ;
Weinstein, DE ;
Palerme, JS ;
Newell, MK .
NATURE CELL BIOLOGY, 2003, 5 (02) :118-125
[6]   Insights into the regulatory mechanism for caspase-8 activation [J].
Donepudi, M ;
Mac Sweeney, A ;
Briand, C ;
Grütter, MG .
MOLECULAR CELL, 2003, 11 (02) :543-549
[7]   Phosphatidylinositide 3-kinase priming couples c-FLIP to T cell activation [J].
Fang, LW ;
Tai, TS ;
Yu, WN ;
Liao, F ;
Lai, MZ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (01) :13-18
[8]   KSHV vFLIP binds to IKK-γ to activate IKK [J].
Field, N ;
Low, W ;
Daniels, M ;
Howell, S ;
Daviet, L ;
Boshoff, C ;
Collins, M .
JOURNAL OF CELL SCIENCE, 2003, 116 (18) :3721-3728
[9]  
Fulda S, 2000, CANCER RES, V60, P3947
[10]   Intracellular localization and transcriptional regulation of tumor necrosis factor (TNF) receptor-associated factor 4 (TRAF4) [J].
Glauner, H ;
Siegmund, D ;
Motejadded, H ;
Scheurich, P ;
Henkler, F ;
Janssen, O ;
Wajant, H .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2002, 269 (19) :4819-4829